Impact Factor
2.90
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.76
249 total citations
h5-index
22
h5 depth signal
Cited share
58.8%
87 of 148
Total citations
249
Citation footprint
Metric signal
2.15
External metric anchor
Self-citation
18.5%
46 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
782
Turkey
66
Canada
60
China
43
United Kingdom
34
Citing Fields of Research
Psychiatry
708
Neurodevelopmental Disorders
485
Psychiatry & Psychology
199
Neurosciences
85
Substance Abuse
67
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,899
Articles tracked across the journal lifetime
Indexed publication set
148
87 cited publications
Last 12 months
114
9.5 publications/month
Open access share
9.6%
11 OA publications in the last year
Leading citing country
United States
782 citing publications
Leading citing field
Psychiatry
708 citing publications
Latest tracked publication
12 October 2026
10 recent records available
Coverage & Indexing History
v6n1,spring 1996-
v6n1,spring 1996-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Neurodevelopmental Disorders
Broad Categories
Pediatrics
Psychopharmacology
Psychiatry
Neurodevelopmental Disorders
MeSH Descriptors
Adolescent Behavior
Adolescent
Child Behavior
Child
Infant
Mental Disorders
Mental Disorders
Psychotropic Drugs
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1177/10445463261497130
Open DOI
Subcutaneous Esketamine in Adolescents with Severe Depressive Episodes: A Five-Case Series
Objective: To describe the feasibility, acute tolerability, and short-term symptom trajectories of adjunctive subcutaneous esketamine in adolescents with severe depressive episodes treated in specialized outpatient care. Methods: This ob...
03
04
DOI 10.1177/10445463261488792
Open DOI
The Art of Prescribing, Toward a Goldilocks Model of Psychotropic Prescribing in Youth
05
DOI 10.1177/10445463261490409
Open DOI
Irritability and Emotion Dysregulation Predict Escitalopram Response in Adolescents with Generalized Anxiety Disorder: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
Objective: Irritability is increasingly recognized as an important aspect of emotion dysregulation in pediatric anxiety disorders. However, the relationship between irritability and treatment outcome in adolescents with generalized anxie...
06
DOI 10.1177/10445463261490857
Open DOI
Association of Habenula Activity and Volume with Pediatric Irritability: Investigation of Inconsistent Parenting as a Moderator
Objective: Irritability significantly impacts the mental health and well-being of youth and their families and is associated with adverse concurrent and future outcomes. Brain abnormalities in the reward system are a potential mechanism ...
07
DOI 10.1177/10445463261490868
Open DOI
Associations Between Autism-Related Characteristics and Tonic Versus Phasic Irritability Across Parent and Teacher Report
Objective: Irritability in youth is increasingly understood as comprising tonic irritability, reflecting persistent irritable mood, and phasic irritability, reflecting acute anger outbursts. This study examined whether these dimensions s...
08
09
DOI 10.1177/10445463261487758
Open DOI
Centanafadine and the Expanding Pharmacologic Landscape of ADHD
10
DOI 10.1177/10445463261484867
Open DOI
Systematic Literature Review on Public Health Impacts of Tourette Syndrome and Persistent Tic Disorders: General Health, Health Conditions, and Health Behaviors
Background: The association of tic disorders and physical health has not been comprehensively described. This systematic review summarized the associations between indicators of physical health (e.g., health-related quality of life [HR-Q...
Bibliographical & Catalog Notes
Quarterly.
Title from cover.
Also issued online.